Cancer Information Group is Publishing in United States that focus on Clinical Colorectal Cancer business. Founded in 1963. They cover business area such as publisher, seven peer-review, disease-specific oncology journal, cut-edge datum, CIG publication, Clinical Breast Cancer, Clinical Colorectal Cancer, Clinical Genitourinary Cancer, Clinical Leukemia, Clinical Lung Cancer, Clinical Lymphoma, Myeloma, supportive Cancer Therapy.
1963
( 61 years old in 2024 )
Clinical Colorectal Cancer
-
3500 Maple Avenue
Suite 750
Dallas, TX 75219
United States
Private
publisherseven peer-review, disease-specific oncology journalcut-edge datumCIG publicationClinical Breast CancerClinical Colorectal CancerClinical Genitourinary CancerClinical LeukemiaClinical Lung CancerClinical LymphomaMyelomasupportive Cancer Therapy
* We use standard office opening hours in near Cancer Information Group's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Cancer Information Group is Publishing business from United States that founded in 1963 (61 years old in 2024), Cancer Information Group business is focusing on Clinical Colorectal Cancer.
Cancer Information Group headquarter office and corporate office address is located in 3500 Maple Avenue Suite 750 Dallas, TX 75219 United States.
Cancer Information Group was founded in United States.
In 2024, Cancer Information Group is currently focus on Clinical Colorectal Cancer sector.
Above is snippet of Google Trends for "Clinical Colorectal Cancer" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Cancer Information Group, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
